MG-X

Bioinspired Drug Delivery System : MG-X

* Swipe to the right and check.

PIPELINE TARGET Discovery Preclinical IND Enabling Clinical
MG-PE3 Alzheimer’s disease
MG-Sh19
MG-G101 Glioblastoma
MG-T101 Immuno-Oncology
MG-N101

We hold innovative biomimetic nanoparticle platform technology that can deliver drugs effectively. We have Alzheimer’s new drug pipelines that enables amyloid beta clearance and ameliorates neuroinflammation mediated by microglia.
Our MEPS-X platform also enables in-depth mechanism studies and more efficient evaluation of our new drug pipelines.

Sitemap닫기

ABOUT
OVERVIEW
VISION
HISTORY
LEADERSHIP
ORGANIZATION
OVERSEAS
CI
CONTACT
TECHNOLOGY
HUMAN ORGAN-ON-A-CHIP
BIOMIMETIC NANOPARTICLE
NANOPARTICLE MANUFACTURING
PIPELINE
MEPS-X
MG-X
SERVICE
SERVICE
NEWS
NOTICE
MEDIA
ARTICLE
CAREERS
CULTURE
HIRING PROCESS
WE'RE HIRING!